Review



ccr3  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Bioss ccr3
    Pathological amelioration of epidermal changes by MSC treatment. a Visualization of histopathological manifestations in dorsal skin sections by hematoxylin–eosin staining. b Epidermis thickness based on tissue sections as presented in a . c Dorsal skin sections stained with toluidine blue to visualize mast cell infiltration. d Quantification of mast cell infiltration based on the number of dark violet-stained cells as presented in c . e Immunochemical staining of CD4, CD8, CD1a, CXCR3, and <t>CCR3</t> of dorsal skin tissue sections. One-way ANOVA with Tukey’s multiple comparison test was used to test statistical significance of epidermal thickness and mast cell infiltration. * P < 0.05; *** P < 0.001; **** P < 0.0001
    Ccr3, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ccr3/product/Bioss
    Average 93 stars, based on 1 article reviews
    ccr3 - by Bioz Stars, 2026-02
    93/100 stars

    Images

    1) Product Images from "Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model"

    Article Title: Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model

    Journal: Stem Cell Research & Therapy

    doi: 10.1186/s13287-023-03365-w

    Pathological amelioration of epidermal changes by MSC treatment. a Visualization of histopathological manifestations in dorsal skin sections by hematoxylin–eosin staining. b Epidermis thickness based on tissue sections as presented in a . c Dorsal skin sections stained with toluidine blue to visualize mast cell infiltration. d Quantification of mast cell infiltration based on the number of dark violet-stained cells as presented in c . e Immunochemical staining of CD4, CD8, CD1a, CXCR3, and CCR3 of dorsal skin tissue sections. One-way ANOVA with Tukey’s multiple comparison test was used to test statistical significance of epidermal thickness and mast cell infiltration. * P < 0.05; *** P < 0.001; **** P < 0.0001
    Figure Legend Snippet: Pathological amelioration of epidermal changes by MSC treatment. a Visualization of histopathological manifestations in dorsal skin sections by hematoxylin–eosin staining. b Epidermis thickness based on tissue sections as presented in a . c Dorsal skin sections stained with toluidine blue to visualize mast cell infiltration. d Quantification of mast cell infiltration based on the number of dark violet-stained cells as presented in c . e Immunochemical staining of CD4, CD8, CD1a, CXCR3, and CCR3 of dorsal skin tissue sections. One-way ANOVA with Tukey’s multiple comparison test was used to test statistical significance of epidermal thickness and mast cell infiltration. * P < 0.05; *** P < 0.001; **** P < 0.0001

    Techniques Used: Staining, Comparison



    Similar Products

    Image Search Results